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INTRODUCTION 
The choice of antibiotics in Africa must be reIat- 
ed to their costleffectiveness: this is particularly true 
in developing countries where resources are scarce 
for individuals and health units as well. 
The goal of this study is to examine the problems 
of infectious diseases in Africa and therapeutic ad- 
vantages of cefu-iaxone. 
IMPORTANCE OF INFECTIOUS DISEASE IN AFRICA 
Infections and parasitic diseases amount to 45% 
of inpatient and 33% of outpatient treatment in 3 
major peripheral hospitals of the Ivory Coast. 
If true parasitic diseases were excluded, and if 
meningitis and pneumonia were counted, the infec- 
tious diseases amount to about 45% of all consulta- 
tions in hospitals. 
About 4 million registered diagnoses are made 
each year in the peripheral health centers in this 
country: 25% of them for infectious diseases. Their 
INSP (Institut National de Santi Publique), .&idjan, Ivory * 
Const. 
high lethal outcome leads to an important death rate 
in hospitals (Table 1). 
AVAILABLE FACILITIES 
Personnel is scarce and outnumbered; during sea- 
sonal epidemics of meningitis or respiratory diseases, 
bed occupation exceeds 100%. The average medical 
staff is as follows: 1 physician for 35 beds, I nurse 
for 12 beds, and 1 nurse-assistant for 6 beds. 
Parasirical or bacteriological aaminatiam u c  
performed in only 510% of the cases and hemato- 
logical examinations in 2-65% of cases. 
Shortage of medical material and drugs oblige 
patients to buy most of them themselves. 
Health conditions of inpatients are usually bad: 
hospital attendance is often delayed for psychologi- 
cal or financial reasons. 
In health centers the average stay is 2 days for 
malaria, 5 days for measles and 13 days for pneumo- 
pathias; for hospitalization it is twice or 3 times that 
long. 
ADVANTAGE OF CEFTRIAXONE 
Ceftriaxone, a third-generation cephalosporin, 
can be particularly beneficial for the following rea- 
sons: a) One single dose a day relieves the staff 
workload; b) high efficacy of the drug can quickly 
bprove  the dinical status of patients; c) a broad- 
spectrum antibiotic is of advantage when bacterio- 
logical resdts are lacking. 
In the treatment of meningitis, a curt: race o f  
90% was observed within 6 days in Niamel (Síger!. 
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dar  results were recorded in Dabou (Ivory Coast) 
:re cure was obtained in 5-7 days for pneumococ- 
or hemophilus meningitis in children. Compara- 
results were also stated by NGU et d. in Yaoundé, 
neroun (personal communication). 
In severe respiratory tract infections we obtained 
d e n t  results, especially in pneumonias resistant 
$lactam antibiotics. Equivalent results were ob- 
:ed by LAMARQUE et al. in Abidjan (Table 2). 
Several other clinical studies were performed in 
ica in the treatment of various infectious diseases 
i as septicemia in newborns, typhoid fever, endo- 
litis, osteomyelitis, peritonitis following obsterri- 
complications, acute abdominal, ORL infections 
In most cases, pranising results were obtained 
ch are similar to those observed in clinical trials 
:urope and North America (However, its use 
At be limited to acute pneumonia when pneumo- 
Us can be incriminated or in the cases of a 
ingococcd meningitis epidemic). 
['his is of particular importance for African pa- 
:S if necessary transfer from remote rural areas to 
ticals or shorter periods of hospitalization are 
ired. 
ophthalmías. 
CONCLUSION - 
>ftriaxone, third-generation cephalosporin, is 
meficial interest in the treatment of infectious 
u ~ f  which often appear under threatening con-. 
N in Africa. 
:s rapid activity and its good penetration into 
